Literature DB >> 8444259

Ear disease is not a common complication in cystic fibrosis.

M Cipolli1, M Canciani, M Cavazzani, P Uras, P Zampieri, G Mastella.   

Abstract

Although upper respiratory tract involvement is a common finding in cystic fibrosis (CF), there is no agreement on whether hearing is affected in these patients. We studied 75 CF subjects and 50 healthy age-matched children with the same audiological protocol. An original scoring system was used to quantify the degree of hearing involvement (normal, mild, moderate and severe) in each subject. Prevalence of ear involvement in children with CF was similar to that in age-matched control subjects (25.4% and 18% respectively, P > 0.05). Ear disease in CF was not related to pulmonary disease, radiological sinusitis, nasal polyposis, or use of parenteral aminoglycosides. These data showed that the risk of ear disease in CF was not increased even if patients with severe audiological involvement were described only in the CF group.

Entities:  

Mesh:

Year:  1993        PMID: 8444259     DOI: 10.1007/bf01956160

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  8 in total

1.  The systematic evaluation of the chest radiograph in cystic fibrosis.

Authors:  A R Chrispin; A P Norman
Journal:  Pediatr Radiol       Date:  1974

2.  [Statistical study of the phonetic composition of the Italian language and its practical application to audiometry of words].

Authors:  E BOCCA; A PELLEGRINI
Journal:  Arch Ital Otol Rinol Laringol       Date:  1950-09

3.  Upper respiratory tract in cystic fibrosis. Ear-nose-throat survey of 50 children.

Authors:  B Taylor; J N Evans; G A Hope
Journal:  Arch Dis Child       Date:  1974-02       Impact factor: 3.791

4.  Hearing loss, speech-language, and cystic fibrosis.

Authors:  R A Forcucci; E W Stark
Journal:  Arch Otolaryngol       Date:  1972-10

5.  The hearing of patients with cystic fibrosis.

Authors:  L L Kulczycki; J S Butler; D McCord-Dickman; G R Herer
Journal:  Arch Otolaryngol       Date:  1970-07

6.  Audiometric testing.

Authors:  J Jerger; J G Neely
Journal:  Arch Otolaryngol       Date:  1971-01

Review 7.  Nasal polyposis, opaque paranasal sinuses and usually normal hearing: the otorhinolaryngological features of cystic fibrosis.

Authors:  T J David
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

8.  Inflammatory middle ear diseases in patients with cystic fibrosis.

Authors:  K Bak-Pedersen; P K Larsen
Journal:  Acta Otolaryngol Suppl       Date:  1979
  8 in total
  4 in total

1.  Changes in the inner ear structures in cystic fibrosis patients.

Authors:  Henrique F Pauna; Rafael C Monsanto; Natsuko Kurata; Michael M Paparella; Sebahattin Cureoglu
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2016-11-16       Impact factor: 1.675

2.  Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort.

Authors:  Chelsea M Blankenship; Lisa L Hunter; M Patrick Feeney; Madison Cox; Lindsey Bittinger; Angela C Garinis; Li Lin; Gary McPhail; John P Clancy
Journal:  Am J Audiol       Date:  2021-01-19       Impact factor: 1.636

3.  cAMP-stimulated Cl- secretion is increased by glucocorticoids and inhibited by bumetanide in semicircular canal duct epithelium.

Authors:  Satyanarayana R Pondugula; Suresh B Kampalli; Tao Wu; Robert C De Lisle; Nithya N Raveendran; Donald G Harbidge; Daniel C Marcus
Journal:  BMC Physiol       Date:  2013-03-27

4.  Otitis media prone children with cystic fibrosis: A new normal.

Authors:  Jennifer L McCoy; Thomas M Kaffenberger; Tiffany S Yang; Joseph E Dohar
Journal:  Am J Otolaryngol       Date:  2021-06-19       Impact factor: 2.873

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.